Breast Cancer Screening Recommendations: Is Mammography the Only Answer?

Authors

  • Anne J. Kearney RN, PhD, MHSc,

    Corresponding author
    1. Anne J. Kearney, RN, PhD, MHSc, is an Assistant Professor in the School of Nursing and Faculty of Medicine, a Principal of the Atlantic Regional Training Centre in Applied Health Services Research, and Acting Codirector of the Centre for Collaborative Health Professional Education at Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
    Search for more papers by this author
  • Michael Murray PhD

    1. Michael Murray, PhD, holds the Chair in Applied Social and Health Psychology and Director, Centre for Psychology Research at Keele University, Keele, Staffordshire, United Kingdom.
    Search for more papers by this author

Rm. 2934, Health Sciences Centre, Memorial University of Newfoundland, St. John's, NL, Canada A1B 3V6. E-mail: akearney@mun.ca

Abstract

Early detection of breast cancer is important to reduce mortality and morbidity. Traditionally, three methods of breast screening were recommended: mammography, clinical breast examination (CBE), and breast self-examination (BSE). At present, BSE and CBE are no longer widely recommended, while mammography is still broadly promoted in the Western world. The primary intent of this article is to examine whether current health policy recommendations related to breast cancer screening are informed by evidence. The issue of whether women are adequately aware of the potential benefits and risks of breast screening methods to make informed decisions is also discussed. It is argued that it is premature to caution women against BSE and CBE because the current evidence is inconclusive or incomplete. Moreover, women should be better informed about the potential harms associated with mammography screening. Recommendations for research and health policy are also discussed.

Ancillary